About ENALARE THERAPEUTICS INC
Enalare Therapeutics is a biopharmaceutical company focused on developing novel therapies for life-threatening acute respiratory and critical care conditions, including drug overdose, post-operative respiratory depression, and apnea of prematurity.
Development of novel compoundsClinical trials for new drug candidatesPatent-protected new chemical entities (NCEs)
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| ENALARE THERAPEUTICS: AN AGNOSTIC RESPIRATORY STIMULANT FOR USE AS A MEDICAL COUNTERMEASURE TO TREAT RESPIRATO | Department of Health and Human Services | $12.2M | |
| Federal contract award | Department of Health and Human Services | $749K |
Is this your company?
Claim ENALARE THERAPEUTICS INC to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim ENALARE THERAPEUTICS INC & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.